Soliphen is a treatment from French company TVM which manages Epilepsy in dogs. The brief was to create campaign materials to help TVM sell Soliphen to its target audience of European Veterinary practices and wholesalers.
The only catch? We weren’t allowed to use photographs of dogs in any of the campaign. This worked for us as after analysing the general market and competition, we found it was saturated with dog photography, and we would never want or recommend creating something which simply blends in.
Along with the logo and big idea for the campaign, we created various forms of campaign collateral with digital firmly part of the campaign strategy pipeline.
TVM has only recently begun marketing Soliphen and we hope to able to share the results of this collaboration in the near future.